Cocaine Use clinical trials at University of California Health
2 in progress, 1 open to eligible people
Showing trials for
Extended-Release Naltrexone and Monthly Extended-Release Buprenorphine for Cocaine Use Disorder (CURB-2)
open to eligible people ages 18-65
This is an 8-week, double-blind, randomized placebo-controlled trial of the efficacy of a combination of extended-release naltrexone (XR-NTX) and extended-release buprenorphine (XR-BUP) compared to matched placebo injections (PBO-Inj) for the…
at UCLA
Profile of Psilocybin for Cocaine Use Disorder
Sorry, not yet accepting patients
The purpose of this study is to establish the safe administration of psilocybin in individuals with cocaine use disorder in terms of cardiovascular (e.g., heart rate) and subjective (e.g., mood) effects. The study's subject population consists of…
at UCLA
Our lead scientists for Cocaine Use research studies include Jesse Clark, MD, MSc Ziva D. Cooper, PhD.
Last updated: